发明授权
US08034828B2 Use of FGF inhibiting substituted 1,2,3 indolizine derivatives in the preparation of medicaments which can be used to treat diseases linked to pathological choroidal angiogenesis
有权
使用FGF抑制的1,2,3-取代的中氮茚衍生物制备可用于治疗与病理性脉络膜血管生成相关的疾病的药物
- 专利标题： Use of FGF inhibiting substituted 1,2,3 indolizine derivatives in the preparation of medicaments which can be used to treat diseases linked to pathological choroidal angiogenesis
- 专利标题（中）： 使用FGF抑制的1,2,3-取代的中氮茚衍生物制备可用于治疗与病理性脉络膜血管生成相关的疾病的药物
-
申请号： US12201075申请日： 2008-08-29
-
公开(公告)号： US08034828B2公开(公告)日： 2011-10-11
- 发明人: Alain Badorc , Francoise Bono , Marie-Francoise Bordes , Jean-Michel Foidart , Nathalie Guillo , Agnes Noel , Jean-Marie Rakic
- 申请人： Alain Badorc , Francoise Bono , Marie-Francoise Bordes , Jean-Michel Foidart , Nathalie Guillo , Agnes Noel , Jean-Marie Rakic
- 申请人地址： FR Paris
- 专利权人： Sanofi-Aventis
- 当前专利权人： Sanofi-Aventis
- 当前专利权人地址： FR Paris
- 代理商 Ronald G. Ort; James W. Bolcsak
- 优先权： FR0401094 20040205
- 主分类号： A61K31/44
- IPC分类号： A61K31/44
摘要：
The present invention thus relates to the use of 1,2,3-substituted indolizine derivatives in the preparation of medicaments of use in the treatment of diseases related to pathological choroidal angiogenesis, which derivatives correspond to the following general formula (I):